Shares of Moderna, Inc. (MRNA) are soaring in intraday trading, with the stock price surging by 9.39% as investors react to reports of potential buyout talks.
According to STAT News, Moderna is reportedly in discussions with at least one large pharmaceutical company regarding a deal of significant scope, which could include a potential buyout. This news has sparked intense interest among investors, driving the stock's dramatic rise.
The biotechnology company, known for its mRNA technology and COVID-19 vaccine, has been a subject of market speculation in recent times. While details of the potential deal remain undisclosed, the mere possibility of a buyout has been enough to trigger a substantial rally in Moderna's stock price. Investors and industry watchers will be closely monitoring further developments in this unfolding story.